Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 145508
Gene Symbol: CEP128
CEP128
0.100 GeneticVariation group GWASCAT Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury. 30299488 2019
Entrez Id: 2067
Gene Symbol: ERCC1
ERCC1
0.010 AlteredExpression group BEFREE Immunohistochemical analysis was used to assess the ERCC1 expression in nasopharyngeal tumor tissues. 29578165 2018
Entrez Id: 3605
Gene Symbol: IL17A
IL17A
0.010 AlteredExpression group BEFREE Expression of miR-135a in the cancer cells isolated from nasopharyngeal tumors was significantly lower than that in NP69 cells, and suppression of IL-17 by miR-135a mimic resulted in significant inhibition of NPC cell proliferation. 29734196 2018
Entrez Id: 6422
Gene Symbol: SFRP1
SFRP1
0.010 PosttranslationalModification group BEFREE KL and SFRP1 methylation were more predominant in nasopharyngeal tumors (P = 0.001 and P = 0.031 respectively). 28812223 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.410 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 2122
Gene Symbol: MECOM
MECOM
0.400 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 55504
Gene Symbol: TNFRSF19
TNFRSF19
0.400 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 1030
Gene Symbol: CDKN2B
CDKN2B
0.100 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 100048912
Gene Symbol: CDKN2B-AS1
CDKN2B-AS1
0.100 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.100 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 81037
Gene Symbol: CLPTM1L
CLPTM1L
0.100 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 81037
Gene Symbol: CLPTM1L
CLPTM1L
0.100 GeneticVariation group GWASCAT An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. 27436580 2016
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.100 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 4261
Gene Symbol: CIITA
CIITA
0.100 GeneticVariation group GWASCAT An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. 27436580 2016
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 GeneticVariation group GWASCAT A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. 26545403 2016
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.100 GeneticVariation group GWASCAT An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. 27436580 2016
Entrez Id: 105375015
Gene Symbol: LINC02571
LINC02571
0.100 GeneticVariation group GWASCAT An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. 27436580 2016
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.100 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 3105
Gene Symbol: HLA-A
HLA-A
0.100 GeneticVariation group GWASCAT An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. 27436580 2016
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
0.100 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 57016
Gene Symbol: AKR1B10
AKR1B10
0.010 AlteredExpression group BEFREE To examine the expression of AKR1B10 at mRNA and protein levels in nasopharyngeal tumors and correlate its expression with clinicopathological parameters. 26835713 2016
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
0.010 Biomarker group BEFREE EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation. 24966947 2014
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.300 Biomarker group CTD_human The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy. 21786012 2012
Entrez Id: 83596
Gene Symbol: BCL2L12
BCL2L12
0.010 AlteredExpression group BEFREE Higher BCL2L12 mRNA levels were detected in undifferentiated carcinomas of the nasopharynx, rather than in nonkeratinizing nasopharyngeal tumors (P = 0.045). 21152697 2011
Entrez Id: 55504
Gene Symbol: TNFRSF19
TNFRSF19
0.400 GeneticVariation group GWASCAT A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010